相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of adverse reactions to antiepileptic drugs
I. Fricke-Galindo et al.
NEUROLOGIA (2018)
Eslicarbazepine acetate exposure in pregnant women with epilepsy
Raquel Costa et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Hyponatremia induced by antiepileptic drugs in patients with epilepsy
Xi Lu et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Instruction manual for the ILAE 2017 operational classification of seizure types
Robert S. Fisher et al.
EPILEPSIA (2017)
The auditory and vestibular toxicities induced by antiepileptic drugs
Sherifa A. Hamed
EXPERT OPINION ON DRUG SAFETY (2017)
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies
S. D. Shorvon et al.
JOURNAL OF NEUROLOGY (2017)
Antiepileptic Drugs and Liver Disease
Jorge Vidaurre et al.
PEDIATRIC NEUROLOGY (2017)
Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications
Adedunni Olusanya et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2017)
Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies
Irene Petersen et al.
CLINICAL EPIDEMIOLOGY (2017)
Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience
Helena Gama et al.
DRUG SAFETY (2017)
Specific adverse effects of antiepileptic drugs - A true-to-life monotherapy study
Alexander B. Kowski et al.
EPILEPSY & BEHAVIOR (2016)
Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia
B. Berghuis et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Severe cutaneous adverse drug reactions
Wen-Hung Chung et al.
JOURNAL OF DERMATOLOGY (2016)
Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review
Tanner J. Bommersbach et al.
MAYO CLINIC PROCEEDINGS (2016)
The role of the temporal pole in modulating primitive auditory memory
Zhiliang Liu et al.
NEUROSCIENCE LETTERS (2016)
T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance
James Yun et al.
ASIA PACIFIC ALLERGY (2016)
Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis
Mahimanjan Saha et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2016)
Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy
Catrin O. Plumpton et al.
EPILEPSIA (2015)
Brivaracetam and carbamazepine interaction in healthy subjects and in vitro
Armel Stockis et al.
EPILEPSY RESEARCH (2015)
The diagnosis and treatment of aplastic anemia: a review
Maurizio Miano et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Pharmacogenomics in the clinic
Mary V. Relling et al.
NATURE (2015)
Antiepileptic drugs and adverse skin reactions: An update
Barbara Blaszczyk et al.
PHARMACOLOGICAL REPORTS (2015)
Dose-Dependent Carbamazepine-Induced Agranulocytosis Following Bariatric Surgery (Sleeve Gastrectomy): A Possible Mechanism
Ioannis Koutsavlis et al.
BARIATRIC SURGICAL PRACTICE AND PATIENT CARE (2015)
Drug-Induced Liver Injury: Pattern Recognition and Future Directions
Tanvir Haque et al.
Gut and Liver (2015)
ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Naga P. Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy
Xiao-Jing He et al.
EPILEPSIA (2014)
Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
Dae Lim Koo et al.
EPILEPSY RESEARCH (2014)
Drug-Induced Liver Injury
Michael D. Leise et al.
MAYO CLINIC PROCEEDINGS (2014)
Anticonvulsant drugs and hematological disease
A. Verrotti et al.
NEUROLOGICAL SCIENCES (2014)
HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients
Ingrid Fricke-Galindo et al.
PHARMACOGENOMICS (2014)
Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy
Chun-Lai Ma et al.
PHARMACOGENOMICS (2014)
Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy
K. Beerhorst et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children
U. Amstutz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
S. G. Leckband et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Prevention of bone loss and vertebral fractures in patients with chronic epilepsy-Antiepileptic drug and osteoporosis prevention trial
Antonio A. Lazzari et al.
EPILEPSIA (2013)
Monitoring the cognitive effects of antiepileptic pharmacotherapy - approaching the individual patient
Juri-Alexander Witt et al.
EPILEPSY & BEHAVIOR (2013)
Multi-Indication Carbamazepine and the Risk of Severe Cutaneous Adverse Drug Reactions in Korean Elderly Patients: A Korean Health Insurance Data-Based Study
Ji Young Kim et al.
PLOS ONE (2013)
The GSTM1 Null Genotype Increased Risk of Gastric Cancer: A Meta-Analysis Based on 46 Studies
Yi Zhao et al.
PLOS ONE (2013)
Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy
Yogita Ghodke Puranik et al.
PHARMACOGENOMICS (2013)
Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: Cohort study using the General Practice Research Database
Jennifer M. Nicholas et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand
Somsak Tiamkao et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2013)
Pharmacogenomics of adverse drug reactions
Ann K. Daly
GENOME MEDICINE (2013)
Chemical properties of antiepileptic drugs (AEDs)
Meir Bialer
ADVANCED DRUG DELIVERY REVIEWS (2012)
HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population
Hiroyuki Niihara et al.
JOURNAL OF DERMATOLOGY (2012)
Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients
Juri-Alexander Witt et al.
JOURNAL OF NEUROLOGY (2012)
Adverse effects of antiepileptic drugs (vol 11, pg 792, 2012)
P. Perucca et al.
LANCET NEUROLOGY (2012)
Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
Di Dong et al.
NEUROLOGY (2012)
Exanthematous Drug Eruptions
Robert S. Stern
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization
Chin-Chuan Hung et al.
PHARMACOGENOMICS (2012)
HLA and pharmacogenetics of drug hypersensitivity
Rebecca Pavlos et al.
PHARMACOGENOMICS (2012)
Self reported adverse effects of mono and polytherapy for epilepsy
Tom Andrew et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Adverse effects of antiepileptic drugs
Piero Perucca et al.
LANCET NEUROLOGY (2012)
Association of Antiepileptic Drugs With Nontraumatic Fractures
Nathalie Jette et al.
ARCHIVES OF NEUROLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PharmGKB summary: carbamazepine pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
The cognitive impact of antiepileptic drugs
Clare M. Eddy et al.
Therapeutic Advances in Neurological Disorders (2011)
Ototoxicity: The Hidden Menace
Manisha Bisht et al.
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2011)
Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients
V. Pulliainen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
A Review of the Effect of Anticonvulsant Medications on Bone Mineral Density and Fracture Risk
Richard H. Lee et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2010)
Drug Reaction With Eosinophilia and Systemic Symptoms A Retrospective Study of 60 Cases
Yi-Chun Chen et al.
ARCHIVES OF DERMATOLOGY (2010)
Bone and calcium metabolism and antiepileptic drugs
Alberto Verrotti et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate
Ian Forsythe et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Patients with epilepsy: Cognitively compromised before the start of antiepileptic drug treatment?
Joanne Taylor et al.
EPILEPSIA (2010)
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy
Maria Paola Canevini et al.
EPILEPSIA (2010)
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers
Denise Milovan et al.
EPILEPSY & BEHAVIOR (2010)
Teratogenic effects of antiepileptic drugs
Denise S. Hill et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
Matti J. Välimäki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy
Ghaydaa A Shehata
Neuropsychiatric Disease and Treatment (2010)
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study
Janneke Jentink et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Pharmacogenetics: The future medicine
Rajiv Saini et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2010)
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy
K. A. Wesnes et al.
EPILEPSY & BEHAVIOR (2009)
Use of Bone Turnover Markers in the Real World: Are We There Yet?
Christian Meier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Adverse antiepileptic drug effects Toward a clinically and neurobiologically relevant taxonomy
Piero Perucca et al.
NEUROLOGY (2009)
Hepatotoxicity associated with antiepileptic drugs
E. Bjornsson
ACTA NEUROLOGICA SCANDINAVICA (2008)
Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine
Robin E. Pearce et al.
DRUG METABOLISM AND DISPOSITION (2008)
Cognitive Effects of Antiepileptic Drugs
Sung-Pa Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2008)
Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects
Ping Ji et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Maja Mockenhaupt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan
C-C Chiou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Pregnancy registries in epilepsy - A consensus statement on health outcomes
K. J. Meador et al.
NEUROLOGY (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Teratogenic effects of antiepileptic drugs
Torbjorn Tomson et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
Hyponatraemia during Low-Dose Carbamazepine Therapy
F. Salawu et al.
ANNALS OF AFRICAN MEDICINE (2007)
The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy
Hoon-Chul Kang et al.
EPILEPSIA (2007)
Idiosyncratic adverse reactions to antiepileptic drugs
Gaetano Zaccara et al.
EPILEPSIA (2007)
Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity
Kentaro Ueda et al.
PHARMACOGENOMICS (2007)
Management of epilepsy during pregnancy
Dina Battino et al.
DRUGS (2007)
Additive effects of antiepileptic drugs and pentylenetetrazole on hearing
Vladimir Nekrassov et al.
NEUROSCIENCE LETTERS (2006)
Speech recognition impairments in patients with intractable right temporal lobe epilepsy
Dana F. Boatman et al.
EPILEPSIA (2006)
Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs
Wolfgang Loescher et al.
EPILEPSIA (2006)
Risk of aplastic anemia in patients using antiepileptic drugs
Kim B. Handoko et al.
EPILEPSIA (2006)
Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy
Marja Alkia et al.
EPILEPSY & BEHAVIOR (2006)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
Clinically relevant drug interactions with antiepileptic drugs
E Perucca
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Multidrug resistance-associated proteins: Expression and function in the central nervous system
Shannon Dallas et al.
PHARMACOLOGICAL REVIEWS (2006)
Carbamazepine-induced hyponatremia: Assessment of risk factors
GM Kuz et al.
ANNALS OF PHARMACOTHERAPY (2005)
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
E Letko et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients
Y Nakajima et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cognitive side effects of antiepileptic drugs
P Ortinski et al.
EPILEPSY & BEHAVIOR (2004)
Pathophysiology of bone loss in patients receiving anticonvulsant therapy
LA Fitzpatrick
EPILEPSY & BEHAVIOR (2004)
Treatment of anticonvulsant drug-induced bone disease
MK Drezner
EPILEPSY & BEHAVIOR (2004)
Tolerability of antiseizure medications - Implications for health outcomes
F Gilliam et al.
NEUROLOGY (2004)
Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs
PN Patsalos et al.
LANCET NEUROLOGY (2003)
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects
WE Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Valproic acid-induced hearing loss and tinnitus
A Hori et al.
INTERNAL MEDICINE (2003)
Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine
A Verrotti et al.
EPILEPSIA (2002)
Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2-and 3-hydroxylated metabolites
RE Pearce et al.
DRUG METABOLISM AND DISPOSITION (2002)
Effect of antiepileptic drugs on bone density in ambulatory patients
G Farhat et al.
NEUROLOGY (2002)
Antiepileptic drug-induced bone loss in young male patients who have seizures
DL Andress et al.
ARCHIVES OF NEUROLOGY (2002)
The importance of drug interactions in epilepsy therapy
PN Patsalos et al.
EPILEPSIA (2002)
Nonchemotherapy drug-induced agranulocytosis:: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature
E Andrès et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2002)
The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures
S Matalon et al.
REPRODUCTIVE TOXICOLOGY (2002)
Differential cognitive and behavioral effects of carbamazepine and lamotrigine
KJ Meador et al.
NEUROLOGY (2001)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
分享论文
